HIF1A and familial pancreatic carcinoma: Moreover, the analyses of the HIF-1α expression level in 48 pancreatic cancer tissues from patients who received adjuvant gemcitabine treatment after pancreatectomy have indicated that HIF-1α expression was associated with an enhanced neo-microvascularity in the hypoxic tumour environment and gemcitabine resistance [12].